Tuesday, June 21, 2011

Addressing an ongoing controversy: Do C1 neurons contribute to resting blood pressure?

Control of sympathetic vasomotor tone by catecholaminergic C1 neurones of the rostral ventrolateral medulla oblongata.


This study was designed to investigate the role of rostral ventral medullary catecholaminergic neurons in the control of resting blood pressure. We all know that most of supraspinal resting vasomotor tone comes from some neurons that "live" in the rostral portion of the ventrolateral medulla (RVLM). We also know that many neurons in RVLM are "C1" neurons, that is, they can synthesize catecholamines. Finally, we know that both C1 and non-C1 neurons send axons to sympathetic preganglionic neurons in the spinal cord, with most being C1. At the time of these discoveries it was assumed that C1 neurons were a major source of resting and relfex RVLM-mediated sympathetic activity. However, studies done in the past ten years have been able to investigate the function of C1 neurons by specifically targeting them with antibodies and viruses. Schreihofer and Guyenet showed that when about 75% of C1 neurons were ablated, sympathoexcitatory responses to direct or reflex-mediated stimulation were markedly reduced, but resting tone of SNA and MAP were unaffected. Further work from this lab showed that specific direct activation of C1 neurons produced increases in SNA and MAP. Also, work from another lab showed that specific "re-expression" of angiotensin II receptors in C1 neurons of an angiotensin receptor knockout mouse model restored SNA responses to angiotensin II in the RVLM. Together, these data suggest a prominent role for C1 neurons in SNS responses but doesn't fully address the role of C1 neurons in the maintanance of resting tone.

The very innovative and unique aspect of this study was the system the authors designed to test direct acute inhibition of C1 neurons in vivo. This was accomplished using lentiviruses specific for C1 neurons, but instead of the virus encoding for something that kills the cell, it encodes an inhibitory G protein-coupled receptor that has a specific ligand (allatostatin) which is not present in mammals. After RVLM injection of the virus and a 5 to 6 week recovery period, rats were anesthetized and instrumented to record MAP and renal SNA. They showed convincingly that acute specific inhibition of C1 neurons in vivo causes a reversible fall in MAP and RSNA in animals that recieved the virus but not in sham rats. They then tested the role of C1 neurons in the SNS response to hypercapnia, or high levels of arterial CO2. Interestingly, if C1 neurons were inhibited before experimentally varying CO2 levels, the response was the same as control. If C1 neurons were inhibited during high CO2, the peak response was attenuated. Also, they suggest that blockade of ionotropic glutamate receptors did not affect this phenomenon. I engourage anyone reading this post to look at the results of this second-to-last experiment and decide for yourself what the results suggest. Finally, they used an isolated heart-brainstem preparation to show that C1 neurons generate much of the respiratory-related SNA bursts.

These data contrast with previous work described. However, the authors note an important distinction in the discussion. By using a toxin that killed C1 neurons over the course of days, other vasomotor centers had the opportunity to increase their activity in compensation. Importantly, they showed in this study that the inhibition was immediate and reversible. Additionally, it appears (to me) that glutamatergic inputs on C1 neurons do have some role in the sympathetic response to hypercapnia, although I admit that the results from this study don't clearly suggest whether they do or do not. Finally, C1 neurons clearly are responsible for respiratory-related bursts of SNA in the authors' in situ  heart-brainstem prep. They could confirm these results in vivo by performing experiments similar to those from Ann Schreihofer's lab of the past 5 years or so.

4 comments:

  1. Nice job Nick, attitude and all! I like the controversy. Any comment on how they determined the percentage of C1 cells that were infected and thus the percentage were inhibited by the allatostatin?? Also, was it given iv or via microinjection -Pat

    ReplyDelete
  2. Good questions. Interestingly, they used a ventral approach to expose the surface of the medulla and they applied the drug directly to the surface.
    Also they metion that their infection rates were 50-55%, matching up very, very nicely with the 50% reductions in MAP and RSNA they see.
    -Nick

    ReplyDelete
  3. So if they were able to infect 100% of the neurons what do you think would happen when they inhibited RVLM? -Pat ;-)

    ReplyDelete
  4. My guess, RSNA would fall around 80% and MAP would fall to spinal levels.

    ReplyDelete